S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:TELA

TELA Bio (TELA) Stock Price, News & Analysis

$5.67
+0.06 (+1.07%)
(As of 03/28/2024 ET)
Today's Range
$5.57
$5.78
50-Day Range
$5.30
$7.61
52-Week Range
$4.23
$11.65
Volume
82,453 shs
Average Volume
122,655 shs
Market Capitalization
$139.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.67

TELA Bio MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
141.0% Upside
$13.67 Price Target
Short Interest
Bearish
2.92% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.29mentions of TELA Bio in the last 14 days
Based on 14 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.61) to ($1.05) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.96 out of 5 stars

Medical Sector

587th out of 938 stocks

Surgical & Medical Instruments Industry

62nd out of 94 stocks

TELA stock logo

About TELA Bio Stock (NASDAQ:TELA)

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

TELA Stock Price History

TELA Stock News Headlines

Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
TELA Bio (NASDAQ:TELA) Rating Reiterated by JMP Securities
A lot of people are making this costly mistake
You may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time.
Q4 2023 TELA Bio Inc Earnings Call
Recap: TELA Bio Q4 Earnings
Tela Bio Announces Commercial Launch Of Liquifix Devices In U.S.
TELA Bio is about to announce its earnings — here's what to expect
TELA Jul 2024 10.000 call
TELA Jul 2024 7.500 put
See More Headlines
Receive TELA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TELA Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
3/28/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:TELA
Fax
N/A
Employees
173
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.67
High Stock Price Target
$15.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+141.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-46,660,000.00
Pretax Margin
-79.83%

Debt

Sales & Book Value

Annual Sales
$58.45 million
Book Value
$0.75 per share

Miscellaneous

Free Float
23,245,000
Market Cap
$139.77 million
Optionable
Optionable
Beta
0.97
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Antony Koblish (Age 58)
    Co-founder, President, CEO & Director
    Comp: $967.67k
  • Mr. Roberto E. Cuca J.D. (Age 56)
    CFO & COO
    Comp: $643.37k
  • Mr. Paul Talmo
    Chief Technology Officer
  • Ms. Megan Smeykal (Age 48)
    VP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer
  • Mr. D. Taylor Ocasio
    General Counsel & Corporate Secretary
  • Ms. Jennifer Lou Armstrong (Age 54)
    Senior Vice President of Human Resources
  • Mr. Gregory A. Firestone
    Chief Business Officer
  • Mr. Michael Leonard
    Senior Vice President of Technical Operations
  • Mr. Peter C. Murphy (Age 51)
    Chief Commercial Officer
    Comp: $542.34k
  • Louisa Smith
    Investor Relations Contact Officer

TELA Stock Analysis - Frequently Asked Questions

Should I buy or sell TELA Bio stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for TELA Bio in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TELA shares.
View TELA analyst ratings
or view top-rated stocks.

What is TELA Bio's stock price target for 2024?

3 Wall Street analysts have issued 1-year target prices for TELA Bio's stock. Their TELA share price targets range from $12.00 to $15.00. On average, they anticipate the company's stock price to reach $13.67 in the next year. This suggests a possible upside of 141.0% from the stock's current price.
View analysts price targets for TELA
or view top-rated stocks among Wall Street analysts.

How have TELA shares performed in 2024?

TELA Bio's stock was trading at $6.62 on January 1st, 2024. Since then, TELA shares have decreased by 14.4% and is now trading at $5.67.
View the best growth stocks for 2024 here
.

When is TELA Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our TELA earnings forecast
.

How were TELA Bio's earnings last quarter?

TELA Bio, Inc. (NASDAQ:TELA) issued its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.57) EPS for the quarter, missing the consensus estimate of ($0.52) by $0.05. The company earned $7.65 million during the quarter, compared to the consensus estimate of $7.30 million. TELA Bio had a negative trailing twelve-month return on equity of 201.62% and a negative net margin of 79.83%.

What guidance has TELA Bio issued on next quarter's earnings?

TELA Bio issued an update on its FY 2024 earnings guidance on Thursday, March, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $74.0 million-$76.0 million, compared to the consensus revenue estimate of $75.2 million.

What other stocks do shareholders of TELA Bio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TELA Bio investors own include Micron Technology (MU), Intel (INTC), Pfizer (PFE), CrowdStrike (CRWD), Walt Disney (DIS), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Alteryx (AYX) and Cisco Systems (CSCO).

When did TELA Bio IPO?

TELA Bio (TELA) raised $60 million in an initial public offering (IPO) on Friday, November 8th 2019. The company issued 4,000,000 shares at $14.00-$16.00 per share. Jefferies and Piper Jaffray served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

Who are TELA Bio's major shareholders?

TELA Bio's stock is owned by a variety of institutional and retail investors. Top institutional investors include First Light Asset Management LLC (10.43%), AIGH Capital Management LLC (5.63%), Nantahala Capital Management LLC (4.48%), Vanguard Group Inc. (4.08%), Vanguard Group Inc. (4.08%) and UBS Group AG (2.81%). Insiders that own company stock include Antony Koblish, Ew Healthcare Partners Fund 2-, Ew Healthcare Partners Fund 2,, Gregory A Firestone, Opaleye Management Inc, Orbimed Advisors Llc and Roberto Cuca.
View institutional ownership trends
.

How do I buy shares of TELA Bio?

Shares of TELA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TELA) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners